Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine sarcoma.

R Belgrad, N Elbadawi, P Rubin

    Radiology
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Treatment strategies for uterine sarcoma vary by subtype. Combined therapy may improve survival for endometrial stromal sarcoma (ESS), while radiation benefits are specific to mixed mesodermal sarcomas (MMS).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for Bs* Bs* production at the Gamma(5S) resonance.

    Physical review letters·2006
    Same author

    Absolute branching fraction measurements of exclusive D+ semileptonic decays.

    Physical review letters·2005
    Same author

    Absolute branching fraction measurements of exclusive D0 semileptonic decays.

    Physical review letters·2005
    Same author

    Search for rare and forbidden decays D+ --> h+/- e+/- e+.

    Physical review letters·2005
    Same author

    Improved measurement of B(D+ --> mu+nu) and the pseudoscalar decay constant fD+.

    Physical review letters·2005
    Same author

    Observation of the hc(1P1) state of charmonium.

    Physical review letters·2005
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    Area of Science:

    • Gynecologic Oncology
    • Surgical Pathology
    • Radiation Oncology

    Background:

    • Uterine sarcomas are rare, aggressive malignancies with diverse pathological features.
    • Treatment response and prognosis vary significantly among different uterine sarcoma subtypes.
    • Optimal therapeutic strategies require careful consideration of histopathology and clinical presentation.

    Purpose of the Study:

    • To analyze the clinicopathologic features of uterine sarcomas.
    • To evaluate the efficacy of different treatment modalities, including surgery and radiation therapy.
    • To correlate pathologic characteristics with patient outcomes and survival rates.

    Main Methods:

    • Retrospective review of 34 uterine sarcoma cases.
    • Analysis of pathologic features, treatment regimens, and patient follow-up data.

    Related Experiment Videos

  • Statistical evaluation of survival rates and local control based on therapy.
  • Main Results:

    • Pathologic features showed variable correlation with clinical course.
    • Combined therapy demonstrated potential survival benefits for endometrial stromal sarcoma (ESS).
    • Adjuvant irradiation improved local control in mixed mesodermal sarcomas (MMS) but not overall survival; its benefit in leiomyosarcoma (LMS) was doubtful.
    • Preoperative irradiation was generally preferred, except for highly malignant MMS requiring immediate surgery.

    Conclusions:

    • Treatment decisions for uterine sarcoma should be individualized based on subtype and malignancy grade.
    • Combined modality approaches, particularly for ESS, warrant further investigation.
    • The role and timing of radiation therapy require careful consideration for specific uterine sarcoma subtypes to optimize outcomes.